| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |